Phaseline

Targets › ATPF0

ATPF0: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 3; Infectious disease; next expected readout Aug 2030.

Open in Phaseline: the race on ATPF0, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Assistance Publique - Hôpitaux de ParisBedaquiline
ATP synthase inhibitor
ATPF0Phase 3MDR-TBAug 2030

Conditions

MDR-TB (1)

Modalities

small molecule (1)

Companies

Assistance Publique - Hôpitaux de Paris (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.